NICE technology appraisal guidance
Issued: September 2002 (last modified: March 2010)
TA47

Guidance on the use of glycoprotein IIb/IIIa inhibitors in the treatment of acute coronary syndromes

View the summary and implementation tools

This is an extract from the guidance. The complete guidance is available at guidance.nice.org.uk/ta47

8 Related guidance

8.1 The Institute issued the original guidance on the use of GP IIb/IIIa inhibitors in September 2000:

  • National Institute for Clinical Excellence (2000) The use of glycoprotein IIb/IIIa inhibitors in the treatment of acute coronary syndromes. NICE Technology Appraisal Guidance No. 12. London: National Institute for Clinical Excellence.

8.2 The Institute issued guidance on the use of coronary artery stents in April 2000:

  • National Institute for Clinical Excellence (2000). The use of coronary artery stents in ischaemic heart disease. NICE Technology Appraisal Guidance No. 4. London: National Institute for Clinical Excellence. [Replaced by NICE technology appraisal guidance 71]